Two North Shore-LIJ Cancer Institute doctors, world-renowned for their research in chronic lymphocytic leukemia (CLL), weigh in on a German study of a new drug therapy for CLL in the New England Journal of Medicine, the North Shore-LIJ Health System has announced.CLL is one of the most common forms of blood cancers, usually affecting those later in life.

More...